This webinar will consider patient-centered approaches in the specific context of Gene Therapy (GT) Long-Term Follow-Up (LTFU) studies. GTs have the potential for long-lasting and transformative health benefits, but there are also possible long-term health risks. Therefore, the FDA recommends long-term safety monitoring of recipients of certain types of GTs to minimize and better understand any health risks. Although important, these LTFU studies can last years and may pose significant burdens on patients, so it is critical to consider patient needs and preferences in the design and conduct of LTFU for GTs. Three panelists will offer different perspectives on how we can put patients at the center of LTFU for GTs.

Register at https://lp.constantcontactpages.com/ev/reg/83r3gyp/lp/13903b2d-e150-44c8-9ae8-8ca48a0ebc62